TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. It develops rolapitant, a potent, selective neurokinin-1 receptor antagonist that can be used for the prevention of chemotherapy-induced nausea and vomiting. The company advances its ALK inhibitor program for oncology indications.

Employee Rating

3.8More
StateClosed
TypeSubsidiary
Parent CompanyGSK
HQWaltham, US
Founded2010
Websitetesarobio.com
Cybersecurity ratingAMore
TESARO was founded in 2010 and is headquartered in Waltham, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at TESARO

Mary Lynne Hedley

Mary Lynne Hedley

President, Chief Operating Officer
William Aitchison

William Aitchison

Senior Vice President, Technical Operations
Greg Covino

Greg Covino

Senior Vice President, Chief Accounting Officer
Allene Diaz

Allene Diaz

Senior Vice President, Global Commercial Development and Program Strategy
Martin Huber

Martin Huber

Senior Vice President, Chief Medical Officer
Jennifer Jackson

Jennifer Jackson

Senior Vice President, Global Regulatory Affairs & Quality Assurance
Show more

TESARO Office Locations

TESARO has offices in Waltham, Wien, Boulogne-Billancourt, München and in 4 other locations
Waltham, US (HQ)
1000 Winter St
Wien, AT
Fleischmarkt 1
Boulogne-Billancourt, FR
235 Avenue le Jour Se Lève
München, DE
Leopoldstraße 37a
Roma, IT
Via Vincenzo Bellini, 22
Madrid, ES
Camino de la Zarzuela, 19, 1ºC
Show all (8)

TESARO Financials and Metrics

Summary Metrics

In total, TESARO had raised $161 m. TESARO is a subsidiary of GSK

TESARO Revenue

TESARO's revenue was reported to be $223.33 m in FY, 2017
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

44.8m223.3m

Revenue growth, %

14040%

Cost of goods sold

268.0k1.3m41.1m

Gross profit

(268.0k)43.6m182.2m
Quarterly
USDQ2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

307.0k36.6m3.7m3.1m29.5m142.8m49.7m57.2m64.4m

Cost of goods sold

76.0k238.0k424.0k444.0k3.6m6.2m10.0m13.5m14.2m

Gross profit

231.0k36.3m3.3m2.6m25.8m136.6m39.7m43.7m50.2m

Gross profit Margin, %

75%99%89%86%88%96%80%76%78%
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

125.4m130.3m256.9m230.1m785.9m643.1m

Accounts Receivable

679.0k5.3m53.4m

Prepaid Expenses

1.2m4.0m1.7m4.6m33.5m

Inventories

1.1m14.7m57.9m
Quarterly
USDQ2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

68.9m138.6m198.6m178.1m156.4m180.3m151.1m295.9m399.1m354.4m302.5m314.5m320.2m647.3m672.2m507.9m521.3m499.0m575.1m476.8m

Accounts Receivable

1.1m1.1m510.0k3.2m6.1m23.1m27.7m44.2m35.7m31.4m

Prepaid Expenses

1.1m1.9m889.0k1.6m1.5m3.3m3.0m1.8m2.2m2.9m4.4m4.2m8.7m7.4m13.6m23.0m22.3m38.2m36.9m31.4m

Inventories

476.0k6.0m8.4m12.2m15.6m28.3m50.5m74.4m87.4m108.8m
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(61.8m)(92.4m)(171.0m)(251.4m)(387.5m)(496.1m)

Depreciation and Amortization

64.0k179.0k349.0k9.5m

Inventories

(1.1m)(13.6m)(60.0m)

Accounts Payable

2.6m(1.3m)4.2m1.9m(2.8m)(1.0m)
USDQ2, 2012

Financial Leverage

7.8 x
Show all financial metrics

TESARO Operating Metrics

FY, 2016

Countries

7

Patent Portfolios

3

Products

2
Show all operating metrics

TESARO Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

TESARO Online and Social Media Presence

Embed Graph

TESARO News and Updates

TESARO BrandVoice: For Some With Ovarian Cancer, New Advancements Allay Unmet Need

Although cancer has at times dampened her spirits, Anna feels more at ease today knowing she has treatment options that aren’t restricted to her genetic makeup.

Lifshitz & Miller LLP Announces Investigation of Apptio, Inc., Black Box Corporation, CURO Group Holdings Corp., Finisar Corporation, Gaming Partners International Corporation, Resolute Energy Corporation, Tesaro, Inc., and Tribune Media Company

NEW YORK, Dec. 28, 2018 /PRNewswire/ -- Apptio, Inc. (APTI) Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the sale of Apptio to Vista Equity Partners for $38.00 per share. If you are an Apptio investor, and would like additional...

GlaxoSmithKline's credit rating revised to negative at Moody's after Tesaro buyout deal

The outlook on GlaxoSmithKline PLC's credit rating was revised to negative from stable at Moody's Investors Service, which cited the drug giant's proposed acquisition of Tesaro Inc. . Moody's affirmed Glaxo's A2 long-term credit rating and its Prime-1 short-term rating. "We have changed [Glaxo's] o…

SHAREHOLDER ALERT: Monteverde & Associates PC Launches An Investigation of the Board of Directors and Officers of Tesaro, Inc. - TSRO

NEW YORK, Dec. 4, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating the Board of Directors and Officers of Tesaro, Inc. ("Tesaro" or the ...

Thinking about buying stock in Atossa Genetics, Cronos Group, New Age Beverages Co, Tesaro Inc. or 22nd Century Group Inc.?

NEW YORK, Dec. 4, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATOS, CRON, NBEV, TSRO, and XXII. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. ...
Show more

TESARO Blogs

TESARO Frequently Asked Questions

  • When was TESARO founded?

    TESARO was founded in 2010.

  • Who are TESARO key executives?

    TESARO's key executives are Mary Lynne Hedley, William Aitchison and Greg Covino.

  • How many employees does TESARO have?

    TESARO has 446 employees.

  • What is TESARO revenue?

    Latest TESARO annual revenue is $223.3 m.

  • What is TESARO revenue per employee?

    Latest TESARO revenue per employee is $500.7 k.

  • Who are TESARO competitors?

    Competitors of TESARO include BeyondSpring, Mirati Therapeutics and Northwest Biotherapeutics.

  • Where is TESARO headquarters?

    TESARO headquarters is located at 1000 Winter St, Waltham.

  • Where are TESARO offices?

    TESARO has offices in Waltham, Wien, Boulogne-Billancourt, München and in 4 other locations.

  • How many offices does TESARO have?

    TESARO has 8 offices.